Trink B - Search Results

1

Plasmas for Treating Cancer: Opportunities for Adaptive and Self-Adaptive Approaches.

Keidar M, Yan D, Beilis II, Trink B, Sherman JH. Keidar M, et al. Among authors: trink b. Trends Biotechnol. 2018 Jun;36(6):586-593. doi: 10.1016/j.tibtech.2017.06.013. Epub 2017 Jul 26. Trends Biotechnol. 2018. PMID: 28755977 Review.

2

Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells.

Guerrero-Preston R, Ogawa T, Uemura M, Shumulinsky G, Valle BL, Pirini F, Ravi R, Sidransky D, Keidar M, Trink B. Guerrero-Preston R, et al. Among authors: trink b. Int J Mol Med. 2014 Oct;34(4):941-6. doi: 10.3892/ijmm.2014.1849. Epub 2014 Jul 11. Int J Mol Med. 2014. PMID: 25050490 Free PMC article.

3

Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy.

Keidar M, Walk R, Shashurin A, Srinivasan P, Sandler A, Dasgupta S, Ravi R, Guerrero-Preston R, Trink B. Keidar M, et al. Among authors: trink b. Br J Cancer. 2011 Oct 25;105(9):1295-301. doi: 10.1038/bjc.2011.386. Epub 2011 Oct 6. Br J Cancer. 2011. PMID: 21979421 Free PMC article.

4

BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus.

Liu D, Xing J, Trink B, Xing M. Liu D, et al. Among authors: trink b. Int J Cancer. 2010 Dec 15;127(12):2965-73. doi: 10.1002/ijc.25304. Int J Cancer. 2010. PMID: 21351275 Free PMC article.

5

Profiling the expression pattern of GPI transamidase complex subunits in human cancer.

Nagpal JK, Dasgupta S, Jadallah S, Chae YK, Ratovitski EA, Toubaji A, Netto GJ, Eagle T, Nissan A, Sidransky D, Trink B. Nagpal JK, et al. Among authors: trink b. Mod Pathol. 2008 Aug;21(8):979-91. doi: 10.1038/modpathol.2008.76. Epub 2008 May 16. Mod Pathol. 2008. PMID: 18487995 Free PMC article.

6

The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204).

Xing J, Liu R, Xing M, Trink B. Xing J, et al. Among authors: trink b. Biochem Biophys Res Commun. 2011 Jan 28;404(4):958-62. doi: 10.1016/j.bbrc.2010.12.088. Epub 2010 Dec 23. Biochem Biophys Res Commun. 2011. PMID: 21185263 Free PMC article.

7

LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.

Upadhyay S, Liu C, Chatterjee A, Hoque MO, Kim MS, Engles J, Westra W, Trink B, Ratovitski E, Sidransky D. Upadhyay S, et al. Among authors: trink b. Cancer Res. 2006 Aug 15;66(16):7870-9. doi: 10.1158/0008-5472.CAN-05-2902. Cancer Res. 2006. PMID: 16912160

8

RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage.

Fomenkov A, Zangen R, Huang YP, Osada M, Guo Z, Fomenkov T, Trink B, Sidransky D, Ratovitski EA. Fomenkov A, et al. Among authors: trink b. Cell Cycle. 2004 Oct;3(10):1285-95. doi: 10.4161/cc.3.10.1155. Epub 2004 Oct 6. Cell Cycle. 2004. PMID: 15467455

9

Habitual risk factors for head and neck cancer.

Goldenberg D, Lee J, Koch WM, Kim MM, Trink B, Sidransky D, Moon CS. Goldenberg D, et al. Among authors: trink b. Otolaryngol Head Neck Surg. 2004 Dec;131(6):986-93. doi: 10.1016/j.otohns.2004.02.035. Otolaryngol Head Neck Surg. 2004. PMID: 15577802 Review.

10

p63 and p73: teammates or adversaries?

Ratovitski E, Trink B, Sidransky D. Ratovitski E, et al. Among authors: trink b. Cancer Cell. 2006 Jan;9(1):1-2. doi: 10.1016/j.ccr.2005.12.027. Cancer Cell. 2006. PMID: 16413463 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page